Immunotherapy and personalised medicine in review

Rationale for combining immunotherapy with chemotherapy

Editor's Choice for March 2016

Patient data: its role in iManageCancer and the p-medicine project

New strategies for ms-based metabolomics

Polycystic kidney disease: Identifying a pathogenic pathway

The occurrence of septic shock: difficulty in predicting the outcomes

Mass spectrometry: a key metabolomics platform in metabolic diseases

Pharmametabolomics and the integration of metabolomics in drug discovery

How can metabolomics help in clinical diagnosis?

Revisiting intrathecal therapy for childhood medulloblastoma

Convection enhanced delivery of chemotherapy to paediatric brain stem tumours